ALEXIS SEKULA: Open Payments
NPI 1407687932 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 41 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $200 · 2025 $1,316
Food & beverage: $1,316
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $455 |
| GENZYME CORPORATION | 10 | $286 |
| Optinose US, Inc. | 4 | $208 |
| GlaxoSmithKline, LLC. | 7 | $190 |
| Medtronic, Inc. | 3 | $72 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $47 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| AtriCure, Inc. | 1 | $19 |
| ALK-Abello, Inc | 1 | $15 |
Products named: DUPIXENT, Xhance, NUCALA, PROPEL, NEFFY, AtriCure cryoICE Cryoablation System (CRYO2), Grastek.
Industry payments across TX — which companies pay providers there.
